Valiant Co.,Ltd

Shenzhen Stock Exchange 002643.SZ

Valiant Co.,Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2023: 11.20%

Valiant Co.,Ltd Return on Capital Employed (ROCE) is 11.20% for the year ending December 31, 2023, a -17.29% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Valiant Co.,Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 13.54%, a 11.15% change year over year.
Valiant Co.,Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 12.18%, a 6.21% change year over year.
Valiant Co.,Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 11.47%, a -5.68% change year over year.
Valiant Co.,Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 12.16%, a 13.10% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Shenzhen Stock Exchange: 002643.SZ

Valiant Co.,Ltd

CEO	Mr. Zhong Li Wang
IPO Date	Dec. 20, 2011
Location	China
Headquarters	11 Wuzhishan Road
Employees	4,635
Sector	Industrials
Industries Petrochemicals Chemicals & Advanced Materials Cleaning Supplies Composite Materials Glass Personal Care Pharmaceuticals Plastics

Description

Valiant Co.,Ltd. produces and sells chemical materials worldwide. The company offers liquid crystal singles and intermediates, OLED singles and intermediates, PI materials, PR monomer, lithium battery additives, and other electronic chemicals. It also provides automobile exhausts purification materials, flue gas denitrification catalysts, VOCs adsorption catalysts, methanol to olefin catalysts, petroleum cracking catalysts, new energy materials, energy-saving lighting materials, organic solar technology, other supporting materials for new energy vehicles, etc. In addition, the company offers API, pharmaceutical intermediates, pharmaceutical formulations, Chinese medicine, and nutrition and health food; life science products related to drug innovation, genomics, proteomics, metabonomics, food health analysis, etc.; and diagnostic reagent products used for the diagnosis of human diseases, such as AIDS, hepatitis, cancer, dengue, cardiovascular and cerebrovascular diseases, etc., as well as for the detection of drug abuse, endocrine levels, and other human conditions. The company was formerly known as Yantai Valiant Fine Chemicals Co., Ltd. and changed its name to Valiant Co.,Ltd. in May 2015. Valiant Co.,Ltd. was founded in 1992 and is headquartered in Yantai, China.

Key trends

Past 5 years